AU5047800A - Breast, gastric and prostate cancer associated antigens and uses therefor - Google Patents
Breast, gastric and prostate cancer associated antigens and uses thereforInfo
- Publication number
- AU5047800A AU5047800A AU50478/00A AU5047800A AU5047800A AU 5047800 A AU5047800 A AU 5047800A AU 50478/00 A AU50478/00 A AU 50478/00A AU 5047800 A AU5047800 A AU 5047800A AU 5047800 A AU5047800 A AU 5047800A
- Authority
- AU
- Australia
- Prior art keywords
- gastric
- breast
- prostate cancer
- associated antigens
- cancer associated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010006187 Breast cancer Diseases 0.000 title 1
- 208000026310 Breast neoplasm Diseases 0.000 title 1
- 206010060862 Prostate cancer Diseases 0.000 title 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 title 1
- 208000005718 Stomach Neoplasms Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 210000000481 breast Anatomy 0.000 title 1
- 206010017758 gastric cancer Diseases 0.000 title 1
- 230000002496 gastric effect Effects 0.000 title 1
- 201000011549 stomach cancer Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001193—Prostate associated antigens e.g. Prostate stem cell antigen [PSCA]; Prostate carcinoma tumor antigen [PCTA]; PAP or PSGR
- A61K39/001194—Prostate specific antigen [PSA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Developmental Biology & Embryology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13652699P | 1999-05-28 | 1999-05-28 | |
US60136526 | 1999-05-28 | ||
US15345499P | 1999-09-10 | 1999-09-10 | |
US60153454 | 1999-09-10 | ||
PCT/US2000/014749 WO2000073801A2 (en) | 1999-05-28 | 2000-05-26 | Breast, gastric and prostate cancer associated antigens and uses therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5047800A true AU5047800A (en) | 2000-12-18 |
Family
ID=26834386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU50478/00A Abandoned AU5047800A (en) | 1999-05-28 | 2000-05-26 | Breast, gastric and prostate cancer associated antigens and uses therefor |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1259812A2 (en) |
JP (1) | JP2003518364A (en) |
AU (1) | AU5047800A (en) |
WO (1) | WO2000073801A2 (en) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6943236B2 (en) | 1997-02-25 | 2005-09-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6630305B1 (en) | 1999-11-12 | 2003-10-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6730477B1 (en) | 1998-08-04 | 2004-05-04 | Diadexus, Inc. | Method of diagnosing, monitoring and staging breast cancer |
US6737040B1 (en) | 1998-08-04 | 2004-05-18 | Diadexus, Inc. | Method and antibody for imaging breast cancer |
EP1006184A1 (en) | 1998-12-03 | 2000-06-07 | F. Hoffmann-La Roche Ag | IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof |
US6844325B2 (en) | 1998-12-28 | 2005-01-18 | Corixa Corporation | Compositions for the treatment and diagnosis of breast cancer and methods for their use |
US6680197B2 (en) | 1998-12-28 | 2004-01-20 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6969518B2 (en) | 1998-12-28 | 2005-11-29 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6590076B1 (en) | 1999-04-02 | 2003-07-08 | Corixa Corporation | Compositions for the treatment and diagnosis of breast cancer and methods for their use |
US6518237B1 (en) | 1998-12-28 | 2003-02-11 | Corixa Corporation | Compositions for treatment and diagnosis of breast cancer and methods for their use |
US6958361B2 (en) | 1998-12-28 | 2005-10-25 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6573368B2 (en) | 1998-12-28 | 2003-06-03 | Corixa Corporation | Compositions for the treatment and diagnosis of breast cancer and methods for their use |
US7598226B2 (en) | 1998-12-28 | 2009-10-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6586572B2 (en) | 1998-12-28 | 2003-07-01 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6528054B1 (en) | 1998-12-28 | 2003-03-04 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6262247B1 (en) * | 1999-08-30 | 2001-07-17 | Incyte Genomics, Inc. | Polycyclic aromatic hydrocarbon induced molecules |
JP5640237B2 (en) * | 1999-11-30 | 2014-12-17 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ リミテッド | Isolated nucleic acid molecule encoding a cancer-associated antigen, the antigen itself and uses thereof |
WO2001040269A2 (en) | 1999-11-30 | 2001-06-07 | Corixa Corporation | Compositions and methods for therapy and diagnosis of breast cancer |
EP1669371A3 (en) * | 1999-12-01 | 2006-06-21 | Genentech, Inc. | Composition and methods for the diagnosis of tumours |
JP2001161374A (en) * | 1999-12-13 | 2001-06-19 | Akihiro Abe | Polynucleotide, polypeptide, medicine for treating cancer, and vaccine |
US6818419B2 (en) | 2000-01-13 | 2004-11-16 | Tularik Inc. | IRAK-4: compositions and methods of use |
AU2001236782A1 (en) * | 2000-02-08 | 2001-08-20 | Agensys, Inc. | 34p3d7: a tissue specific protein highly expressed in prostate cancer |
WO2001077168A2 (en) * | 2000-04-11 | 2001-10-18 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
AU2002227365A1 (en) | 2000-12-07 | 2002-06-18 | Chiron Corporation | Endogenous retroviruses up-regulated in prostate cancer |
AU2002231736A1 (en) | 2000-12-22 | 2002-07-08 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Use of repulsive guidance molecule (rgm) and its modulators |
GB0031430D0 (en) | 2000-12-22 | 2001-02-07 | Norsk Hydro As | Polypeptides |
WO2002072610A2 (en) * | 2001-03-14 | 2002-09-19 | The Regents Of The University Of California | Rbp1l1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof |
US20030044813A1 (en) * | 2001-03-30 | 2003-03-06 | Old Lloyd J. | Cancer-testis antigens |
US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
AU2002318112B2 (en) * | 2001-04-10 | 2007-12-06 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
ATE415418T1 (en) * | 2001-04-10 | 2008-12-15 | Agensys Inc | NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 121P2A3 FOR THE TREATMENT AND DETECTION OF CANCER |
KR100405919B1 (en) | 2001-06-05 | 2003-11-14 | 주식회사 이매진 | Pharmaceutical composition for immunological enhancement comprising N-terminal peptide of p43 as an effective component |
DE60235413D1 (en) * | 2001-12-07 | 2010-04-01 | Novartis Vaccines & Diagnostic | IN PROSTATE CANCER HIGHLY REGULATED ENDOGENIC RETROVIRUS |
US7147855B2 (en) | 2001-12-07 | 2006-12-12 | Juan Saus | GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein |
WO2003089608A2 (en) | 2002-04-18 | 2003-10-30 | The General Hospital Corporation | Drg11-responsive (dragon) gene family |
JP2004057003A (en) * | 2002-06-03 | 2004-02-26 | Norihiro Chano | Rb1 gene-induced protein (rb1cc1) and gene |
AU2003276679A1 (en) | 2002-06-13 | 2003-12-31 | Chiron Corporation | Vectors for expression of hml-2 polypeptides |
EP1380644A1 (en) * | 2002-07-08 | 2004-01-14 | Kylix B.V. | The use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role |
FR2849039B1 (en) * | 2002-12-24 | 2010-10-01 | Centre Nat Rech Scient | NOVEL PROTEIN ASSOCIATED WITH CENTROSOMES AND ITS APPLICATIONS |
US20070166711A1 (en) | 2003-04-15 | 2007-07-19 | Samuels Mark E | Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof |
US20060141528A1 (en) * | 2004-05-21 | 2006-06-29 | Aebersold Rudolf H | Compositions and methods for quantification of serum glycoproteins |
CA2579558A1 (en) * | 2004-09-08 | 2006-03-16 | Ludwig Institute For Cancer Research | Cancer-testis antigens |
CN101277974A (en) | 2005-09-30 | 2008-10-01 | 阿伯特有限及两合公司 | Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use |
WO2008047473A1 (en) | 2006-10-17 | 2008-04-24 | Oncotherapy Science, Inc. | Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
ES2562832T3 (en) | 2009-12-08 | 2016-03-08 | Abbvie Deutschland Gmbh & Co Kg | Monoclonal antibodies against the RGM protein for use in the treatment of degeneration of the retinal nerve fiber layer |
CA2804424C (en) | 2010-07-12 | 2021-03-30 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
DK2807192T3 (en) | 2012-01-27 | 2018-07-23 | Abbvie Deutschland | COMPOSITION AND PROCEDURE FOR DIAGNOSTICATION AND TREATMENT OF DISEASES RELATED TO NEURITE DEGENERATION |
EP2814514B1 (en) | 2012-02-16 | 2017-09-13 | Atyr Pharma, Inc. | Histidyl-trna synthetases for treating autoimmune and inflammatory diseases |
EP2854842A4 (en) | 2012-05-25 | 2016-11-02 | Agenus Inc | Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategies |
CA2883569A1 (en) | 2012-08-31 | 2014-03-06 | University Of Virginia Patent Foundation | Target peptides for immunotherapy and diagnostics |
EP4088737A3 (en) | 2012-09-05 | 2023-02-08 | University Of Virginia Patent Foundation | Target peptides for colorectal cancer therapy and diagnostics |
EP2931312A4 (en) * | 2012-12-13 | 2016-10-19 | Univ Virginia Patent Found | Target peptides for ovarian cancer therapy and diagnostics |
AU2014233436B2 (en) | 2013-03-15 | 2019-12-05 | Atyr Pharma, Inc. | Histidyl-tRNA synthetase-Fc conjugates |
CA2945816A1 (en) | 2014-04-15 | 2015-10-22 | University Of Virginia Patent Foundation | Isolated t cell receptors and methods of use therefor |
SG11201802286PA (en) | 2015-10-08 | 2018-04-27 | Oncotherapy Science Inc | Mphosph1-derived peptide, and vaccine including same |
EP3612215B1 (en) | 2017-04-20 | 2024-08-28 | aTyr Pharma, Inc. | Compositions for treating lung inflammation |
EP3827263A1 (en) * | 2018-07-26 | 2021-06-02 | Frame Pharmaceuticals B.V. | Cancer vaccines for colorectal cancer |
CN109055555B (en) * | 2018-08-27 | 2021-09-21 | 中山大学 | Lung cancer early stage metastasis diagnosis marker and kit and application thereof |
CN114606324B (en) * | 2022-05-10 | 2022-08-05 | 上海晟燃生物科技有限公司 | Kit and system for assisting low-dose CT in screening lung cancer |
-
2000
- 2000-05-26 EP EP00932804A patent/EP1259812A2/en not_active Withdrawn
- 2000-05-26 JP JP2001500870A patent/JP2003518364A/en active Pending
- 2000-05-26 WO PCT/US2000/014749 patent/WO2000073801A2/en not_active Application Discontinuation
- 2000-05-26 AU AU50478/00A patent/AU5047800A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1259812A2 (en) | 2002-11-27 |
WO2000073801A2 (en) | 2000-12-07 |
WO2000073801A3 (en) | 2002-09-12 |
JP2003518364A (en) | 2003-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5047800A (en) | Breast, gastric and prostate cancer associated antigens and uses therefor | |
AU2002212527A1 (en) | Thermometry-based breast cancer risk assessment | |
AU2001229682A1 (en) | Small cell lung cancer associated antigens and uses therefor | |
AU2002362454A1 (en) | Regulated breast cancer genes | |
AU2002311869A1 (en) | Breast cancer-associated genes and uses thereof | |
AUPR395801A0 (en) | Antibodies against cancer | |
AU2001290860A1 (en) | Spas-1 cancer antigen | |
AU2002349543A1 (en) | Tumor antigens | |
AU2003302165A8 (en) | Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof. | |
AU2948199A (en) | Breast cancer antigen | |
MXPA02004942A (en) | Use of anti idiotypical antibodies as vaccines against cancer. | |
AU6278300A (en) | Tumor-associated antigen (r11) | |
AU2001288921A1 (en) | Human breast cancer biomarkers | |
AU3283500A (en) | Tumor-associated antigen | |
AU5632500A (en) | Cancer associated antigens and uses therefor | |
ZA200203166B (en) | Treatment of cancer. | |
HUP0202270A2 (en) | Antitumor antibodies, proteins, and uses thereof | |
AU1392801A (en) | Casb7434, an antigen over-expressed in colon cancer | |
AU2002326318A1 (en) | Targeting tumor cell antigens: antibodies useful for the diagnosis, prognosis, and treatment of cancer | |
AU2194301A (en) | Breast pad | |
AU2002363807A1 (en) | Breast cancer associated polypeptide | |
AU5162400A (en) | Cancer associated antigens and uses therefor | |
AU4553100A (en) | Tumour-associated antigen | |
AU7788600A (en) | Colon-tumour-associated antigens | |
AU4598100A (en) | Treating cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |